Atlas Trials

Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg

Clinical trial NCT01376115 · COMPLETED

Trial details

NCT number
NCT01376115
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Study type
OBSERVATIONAL
Cancer
Start date
2008-01-18
Primary completion
2017-10-24
Enrollment
343

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.